Thermo Fisher Scientific Income from Continuous Operations 2010-2024 | TMO
Thermo Fisher Scientific annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Thermo Fisher Scientific income from continuous operations for the quarter ending December 31, 2024 was $1.825B, a 13.64% increase year-over-year.
- Thermo Fisher Scientific income from continuous operations for the twelve months ending December 31, 2024 was $6.338B, a 6.43% increase year-over-year.
- Thermo Fisher Scientific annual income from continuous operations for 2024 was $6.338B, a 6.43% increase from 2023.
- Thermo Fisher Scientific annual income from continuous operations for 2023 was $5.955B, a 14.44% decline from 2022.
- Thermo Fisher Scientific annual income from continuous operations for 2022 was $6.96B, a 9.94% decline from 2021.
| Thermo Fisher Scientific Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $6,338 |
| 2023 | $5,955 |
| 2022 | $6,960 |
| 2021 | $7,728 |
| 2020 | $6,377 |
| 2019 | $3,698 |
| 2018 | $2,938 |
| 2017 | $2,228 |
| 2016 | $2,025 |
| 2015 | $1,980 |
| 2014 | $1,896 |
| 2013 | $1,279 |
| 2012 | $1,258 |
| 2011 | $1,023 |
| 2010 | $986 |
| 2009 | $823 |
| Thermo Fisher Scientific Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,825 |
| 2024-09-30 | $1,629 |
| 2024-06-30 | $1,553 |
| 2024-03-31 | $1,331 |
| 2023-12-31 | $1,606 |
| 2023-09-30 | $1,695 |
| 2023-06-30 | $1,362 |
| 2023-03-31 | $1,292 |
| 2022-12-31 | $1,574 |
| 2022-09-30 | $1,498 |
| 2022-06-30 | $1,668 |
| 2022-03-31 | $2,220 |
| 2021-12-31 | $1,659 |
| 2021-09-30 | $1,903 |
| 2021-06-30 | $1,829 |
| 2021-03-31 | $2,337 |
| 2020-12-31 | $2,500 |
| 2020-09-30 | $1,933 |
| 2020-06-30 | $1,156 |
| 2020-03-31 | $788 |
| 2019-12-31 | $1,004 |
| 2019-09-30 | $760 |
| 2019-06-30 | $1,119 |
| 2019-03-31 | $815 |
| 2018-12-31 | $898 |
| 2018-09-30 | $709 |
| 2018-06-30 | $752 |
| 2018-03-31 | $579 |
| 2017-12-31 | $530 |
| 2017-09-30 | $534 |
| 2017-06-30 | $613 |
| 2017-03-31 | $551 |
| 2016-12-31 | $632 |
| 2016-09-30 | $474 |
| 2016-06-30 | $517 |
| 2016-03-31 | $402 |
| 2015-12-31 | $606 |
| 2015-09-30 | $477 |
| 2015-06-30 | $512 |
| 2015-03-31 | $385 |
| 2014-12-31 | $604 |
| 2014-09-30 | $470 |
| 2014-06-30 | $279 |
| 2014-03-31 | $543 |
| 2013-12-31 | $343 |
| 2013-09-30 | $318 |
| 2013-06-30 | $278 |
| 2013-03-31 | $341 |
| 2012-12-31 | $386 |
| 2012-09-30 | $299 |
| 2012-06-30 | $292 |
| 2012-03-31 | $281 |
| 2011-12-31 | $293 |
| 2011-09-30 | $266 |
| 2011-06-30 | $217 |
| 2011-03-31 | $247 |
| 2010-12-31 | $274 |
| 2010-09-30 | $259 |
| 2010-06-30 | $229 |
| 2010-03-31 | $225 |
| 2009-12-31 | $246 |
| 2009-09-30 | $221 |
| 2009-06-30 | $207 |
| 2009-03-31 | $149 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $161.378B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $171.942B | 78.88 |
| Alcon (ALC) | Switzerland | $45.645B | 30.34 |
| Edwards Lifesciences (EW) | United States | $42.050B | 27.30 |
| IDEXX Laboratories (IDXX) | United States | $33.347B | 38.56 |
| DexCom (DXCM) | United States | $26.887B | 41.56 |
| IQVIA Holdings (IQV) | United States | $25.374B | 14.04 |
| STERIS (STE) | Ireland | $21.834B | 24.97 |
| Mettler-Toledo (MTD) | United States | $20.944B | 24.42 |
| Waters (WAT) | United States | $19.099B | 27.04 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.304B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.878B | 14.16 |
| Hologic (HOLX) | United States | $12.916B | 13.94 |
| Sysmex ADR (SSMXY) | Japan | $11.847B | 0.00 |
| Penumbra (PEN) | United States | $10.729B | 96.64 |
| Globus Medical (GMED) | United States | $9.767B | 22.61 |
| Masimo (MASI) | United States | $8.221B | 34.50 |
| Teleflex (TFX) | United States | $6.004B | 9.24 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.081B | 22.07 |
| TransMedics (TMDX) | United States | $2.985B | 87.37 |
| PROCEPT BioRobotics (PRCT) | United States | $2.907B | 0.00 |
| Veracyte (VCYT) | United States | $2.427B | 43.86 |
| Nihon Kohden (NHNKY) | Japan | $2.081B | 11.37 |
| LivaNova (LIVN) | United Kingdom | $1.934B | 11.74 |
| Elekta AB (EKTAY) | Sweden | $1.891B | 17.00 |
| Alphatec Holdings (ATEC) | United States | $1.522B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.18 |
| Pulse Biosciences (PLSE) | United States | $1.193B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Paragon 28 (FNA) | United States | $1.099B | 0.00 |
| Artivion (AORT) | United States | $0.979B | 91.72 |
| OPKO Health (OPK) | United States | $0.954B | 0.00 |
| AxoGen (AXGN) | United States | $0.690B | 0.00 |
| IRadimed (IRMD) | United States | $0.658B | 34.51 |
| Mesa Laboratories (MLAB) | United States | $0.609B | 13.30 |
| SiBone (SIBN) | United States | $0.588B | 0.00 |
| RxSight (RXST) | United States | $0.584B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 9.21 |
| OrthoPediatrics (KIDS) | United States | $0.510B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.508B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.483B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.406B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.351B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.315B | 16.87 |
| Semler Scientific (SMLR) | United States | $0.312B | 6.62 |
| Neuronetics (STIM) | United States | $0.247B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.181B | 0.00 |
| 908 Devices (MASS) | United States | $0.168B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.152B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.110B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.104B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |